Masaya Shigeno

984 total citations
13 papers, 599 citations indexed

About

Masaya Shigeno is a scholar working on Hepatology, Epidemiology and Cancer Research. According to data from OpenAlex, Masaya Shigeno has authored 13 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hepatology, 5 papers in Epidemiology and 5 papers in Cancer Research. Recurrent topics in Masaya Shigeno's work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Liver Disease Diagnosis and Treatment (3 papers) and Hepatitis B Virus Studies (3 papers). Masaya Shigeno is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Liver Disease Diagnosis and Treatment (3 papers) and Hepatitis B Virus Studies (3 papers). Masaya Shigeno collaborates with scholars based in Japan and Indonesia. Masaya Shigeno's co-authors include Kazuhiko Nakao, Tatsuki Ichikawa, Keisuke Hamasaki, Hiroki Ishikawa, Seigou Abiru, Katsumi Eguchi, Seiji Miyazoe, Yuichi Nakagawa, Keisuke Nakata and Kazuyuki Ohata and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Cancer.

In The Last Decade

Masaya Shigeno

13 papers receiving 586 citations

Peers

Countries citing papers authored by Masaya Shigeno

Since Specialization

Citations

This map shows the geographic impact of Masaya Shigeno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaya Shigeno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaya Shigeno more than expected).

Fields of papers citing papers by Masaya Shigeno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaya Shigeno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaya Shigeno. The network helps show where Masaya Shigeno may publish in the future.

Co-authorship network of co-authors of Masaya Shigeno

This figure shows the co-authorship network connecting the top 25 collaborators of Masaya Shigeno. A scholar is included among the top collaborators of Masaya Shigeno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaya Shigeno. Masaya Shigeno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Effects of nanocurcumin supplementation on metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials 2025 ·Pharmacological Research ·Gofarana Wilar, Cecep Suhandi, Kohji Fukunaga, Masaya Shigeno, K. Kawahata, Rizky Abdulah, Takuya Sasaki	2
2	Evaluating the Role of Hepatobiliary Phase of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Predicting Treatment Impact of Lenvatinib and Atezolizumab plus Bevacizumab on Unresectable Hepatocellular Carcinoma 2022 ·Cancers ·Ryu Sasaki, (unknown), Masanori Fukushima, (unknown), Satoshi Miuma, Hisamitsu Miyaaki, Akihiko Soyama, Masaaki Hidaka, Susumu Eguchi, Masaya Shigeno, (unknown), (unknown), Tatsuki Ichikawa, Yuki Kugiyama, Hiroshi Yatsuhashi, Kazuhiko Nakao	29
3	Liver Function in Older Patients With Unresectable Hepatocellular Carcinoma After Administration of Lenvatinib 2021 ·Anticancer Research ·Ryu Sasaki, Masanori Fukushima, (unknown), Satoshi Miuma, Hisamitsu Miyaaki, Masaaki Hidaka, Susumu Eguchi, Satoshi Matsuo, Toshihisa Matsuzaki, (unknown), Kazuo Ohba, Yuki Kugiyama, Hiroshi Yatsuhashi, Hidetaka Shibata, Yasuhide Motoyoshi, Masaya Shigeno, (unknown), Yuji Kato, (unknown), Kazuhiko Nakao	7
4	Response to Lenvatinib Is Associated with Optimal RelativeDose Intensity in Hepatocellular Carcinoma: Experience in Clinical Settings 2019 ·Cancers ·Ryu Sasaki, Masanori Fukushima, (unknown), Satoshi Miuma, Hisamitsu Miyaaki, Masaaki Hidaka, Susumu Eguchi, Satoshi Matsuo, (unknown), Toshihisa Matsuzaki, (unknown), (unknown), Yuki Kugiyama, Hiroshi Yatsuhashi, Yasuhide Motoyoshi, Masaya Shigeno, (unknown), Kazuhiko Nakao	37
5	The efficacy and safety of lenvatinib in patients who did not meet the inclusion criteria of the phase 3 trial (REFLECT trial) in real-world practice in Japan: A nationwide multicenter study in Japan. 2019 ·Journal of Clinical Oncology ·Kaoru Tsuchiya, Masayuki Kurosaki, Hiroyuki Marusawa, Takehiko Abe, Chikara Ogawa, Tetsuro Sohda, Hiroyuki Kimura, Masahiko Kondo, Keiji Tsuji, Koichiro Furuta, Masaya Shigeno, Kouji Joko, Ryoichi Narita, Yasushi Uchida, Hideo Yoshida, Takehiro Akahane, Haruhiko Kobashi, Akeri Mitsuda, Yuji Kojima, Namiki Izumi, (unknown)	3
6	Rectal Paraganglioma 2018 ·Internal Medicine ·(unknown), (unknown), (unknown), Koichiro Kusumoto, Kazuyuki Ohata, Kazuto Shigematsu, Masaya Shigeno	2
7	Interferon alpha inhibits the nuclear factor kappa B activation triggered by X gene product of hepatitis B virus in human hepatoma cells 2003 ·FEBS Letters ·Kazuyuki Ohata, Tatsuki Ichikawa, Kazuhiko Nakao, Masaya Shigeno, Daisuke Nishimura, Hiroki Ishikawa, Keisuke Hamasaki, Katsumi Eguchi	12
8	Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection 2003 ·Cancer ·Kazuyuki Ohata, Keisuke Hamasaki, Kan Toriyama, Kojiro Matsumoto, Akira Saeki, Kenji Yanagi, Seigou Abiru, Yuichi Nakagawa, Masaya Shigeno, Seiji Miyazoe, Tatsuki Ichikawa, Hiroki Ishikawa, Kazuhiko Nakao, Katsumi Eguchi	253
9	Interferon-α sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-κB inactivation 2003 ·Oncogene ·Masaya Shigeno, Kazuhiko Nakao, Tatsuki Ichikawa, (unknown), Atsushi Kawakami, Seigou Abiru, Seiji Miyazoe, Yuichi Nakagawa, Hiroki Ishikawa, Keisuke Hamasaki, Keisuke Nakata, Nobuko Ishii, Katsumi Eguchi	96
10	Involvement of IL-1β and IL-10 in IFN-α-mediated antiviral gene induction in human hepatoma cells 2002 ·Biochemical and Biophysical Research Communications ·Tatsuki Ichikawa, Kazuhiko Nakao, Keisuke Nakata, (unknown), Keisuke Hamasaki, Masaya Shigeno, Seigou Abiru, Hiroki Ishikawa, Nobuko Ishii, Katsumi Eguchi	32
11	Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells 2002 ·Hepatology ·Seigou Abiru, Kazuhiko Nakao, Tatsuki Ichikawa, Kiyoshi Migita, Masaya Shigeno, (unknown), Hiroki Ishikawa, Keisuke Hamasaki, Keisuke Nakata, Katsumi Eguchi	90
12	Geranylgeraniol, an Intermediate Product in Mevalonate Pathway, Induces Apoptotic Cell Death in Human Hepatoma Cells: Death Receptor‐independent Activation of Caspase‐8 with Down‐regulation of Bcl‐xL Expression 2001 ·Japanese Journal of Cancer Research ·Yoshio Takeda, Kazuhiko Nakao, Keisuke Nakata, Atsushi Kawakami, Hiroaki Ida, Tatsuki Ichikawa, Masaya Shigeno, (unknown), Keisuke Hamasaki, Yuji Kato, Katsumi Eguchi	24
13	Acquired nephrogenic diabetes insipidus secondary to distal renal tubular acidosis and nephrocalcinosis associated with Sjögren’s syndrome 1994 ·Journal of Endocrinological Investigation ·Yuji Nagayama, Masaya Shigeno, Yoichi Nakagawa, (unknown), Akira Takeshita, (unknown), K Ashizawa, (unknown), Naokata Yokoyama, Shigenobu Nagataki	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact